The present study was carried out to confirm the
efficacy of a moxidectin microsphere sustained release
formulation (moxidectin SR) for the prevention of subcutaneous
dirofilariosis when administered six months
after experimental infection in dogs.
2. Materials and methods
The study was designed and conducted in accordance
with VICH GL7 (efficacy of anthelmintics: general requirements),
VICH GL19 (effectiveness of anthelmintics: specific
recommendations for canine), the World Association for
the Advancement of Veterinary Parasitology (WAAVP)
guidelines for evaluating the efficacy of anthelmintics for
dogs and cats (Jacobs et al., 1994), the International
harmonization of anthelmintic efficacy guidelines (Part 2)
(Vercruysse et al., 2002) and with the agreement of the
Italian Ministry of Health.